Featured Posts
Blog
This week in health care policy: September 28 – October 2, 2026
Drug pricing CMS finalizes GLOBE pilot. On September 30, CMS finalized the Global Benchmark for Efficient Drug Pricing model, a…
National Review
Prescription Drugs Save Lives at a (Mostly) Reasonable Cost
Prescription drugs are an extraordinary lifesaving and life-enhancing technology, so integrated into our daily lives that, nowadays, we perhaps take them for granted. Headlines and…
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Search Posts
City Journal
Nature’s Vaccine
Public-health officials in the U.S., unlike their counterparts elsewhere, have steadfastly focused on Covid-19 vaccines in fighting the pandemic, acting as if natural immunity…
Wall Street Journal
Don’t Let Unspent Covid Funds Become Slush Funds
The House has passed the Limit, Save, Grow Act, which would raise the debt limit for a year in exchange for deficit-relief measures. One…
National Review
No, Lockdown States Did Not Do Better
Many politicians, public-health figures, and media pundits continue to insist that the Covid lockdowns were a success and represent a blueprint for future pandemic responses.
City Journal
Politically Correct Medical Scholarship Doesn’t Help Blacks
A recent article in the British Medical Journal, “Inequities in surgical outcomes by race and sex in the United States,” is…
National Review
Was the U.S. furtively funding the lab research that unleashed Covid-19?
Slowly but surely, new cracks are appearing in the wall of silence denying Chinese culpability in causing the nearly 7 million deaths attributed…
Blog
Covid Lockdowns Did Not Improve Outcomes: Lessons from Florida and California
My Competitive Enterprise Institute colleague Dr. Joel Zinberg is the co-author of a new report, published by the Paragon Health Institute titled “Freedom…